| Presented by: | The Cleveland Clinic Foundation Center for Continuing Education |
| Lecturer | Leonard Calabrese, DO and Yusuf Yazici, MD |
| Approximate duration: | 1 hr. |
| Summary points: | This CME activity discusses treatment options for a patient with rheumatoid arthritis, including recent evidence highlighting the value of nonbiologic disease-modifying antirheumatic drugs in current therapy. |
| Accreditation: | The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit.
Expiration Date: August 31, 2010. |
| Other: | |